Drug Profile
Anti-rabies immunoglobulin - OncoBioMune
Latest Information Update: 06 Jan 2023
Price :
$50
*
At a glance
- Originator Unknown
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Rabies